High Outlier
Strength
4.6 mg/24h
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078050115
Classification
Brand
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Last Updated
9/17/2025
Active Ingredients
RIVASTIGMINEApproval Type
New Drug (NDA)
FDA Application
NDA022083On Market Since
7/6/2007
Pharmacological Classes
Cholinesterase Inhibitor
Cholinesterase Inhibitors
Related Drugs
Same classification
MESTINON 60 MG/5 ML SYRUP
Brand
00187301220•Bausch Health US LLC
$1.9930
per ML
ARICEPT 23 MG TABLET
Brand
62856024730•Eisai Inc.
$14.3864
per EA
ARICEPT 10 MG TABLET
Brand
62856024630•Eisai Inc.
$16.1969
per EA
ARICEPT 5 MG TABLET
Brand
62856024530•Eisai Inc.
$16.4368
per EA
NAMZARIC 21 MG-10 MG CAPSULE
Brand
00456122130•Allergan, Inc.
$19.7649
per EA
NAMZARIC 28 MG-10 MG CAPSULE
Brand
00456122830•Allergan, Inc.
$19.8156
per EA
NAMZARIC 7 MG-10 MG CAPSULE
Brand
00456120730•Allergan, Inc.
$19.8250
per EA
NAMZARIC 14 MG-10 MG CAPSULE
Brand
00456121430•Allergan, Inc.
$19.8307
per EA
MESTINON 60 MG TABLET
Brand
00187301030•Bausch Health US LLC
$20.7334
per EA
MESTINON 180 MG TIMESPAN
Brand
00187301330•Bausch Health US LLC
$39.3384
per EA